Re: monitoring patients on antimalarials: where are we now? Author reply.
Michael
M
Easterbrook
D000962:Antimalarials / Q000009:adverse effects*; D003117:Color Vision Defects / Q000139:chemically induced*; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects*; D012160:Retina / Q000187:drug effects*; D012607:Scotoma / Q000139:chemically induced*; D014794:Visual Fields / Q000187:drug effects*
D000962:Antimalarials; D006886:Hydroxychloroquine